11 results
10-Q
2022 Q1
HLVX
HilleVax Inc
8 Jun 22
Quarterly report
4:25pm
an injunction against its manufacture or distribution;
we may be required to recall a vaccine or change the way such vaccine is administered … . Failure to comply with these regulations may require us to repeat clinical trials or recall batches of our vaccine candidate, which would delay
424B4
HLVX
HilleVax Inc
29 Apr 22
Prospectus supplement with pricing info
4:02pm
or distribution;
we may be required to recall a vaccine or change the way such vaccine is administered to individuals;
regulatory authorities may require … with vaccine candidates produced under cGMP regulations. Failure to comply with these regulations may require us to repeat clinical trials or recall batches
S-1/A
HLVX
HilleVax Inc
18 Apr 22
IPO registration (amended)
6:08am
or seek an injunction against its manufacture or distribution;
we may be required to recall a vaccine or change the way such vaccine is administered … require us to repeat clinical trials or recall batches of our vaccine candidate, which would delay the regulatory approval process.
There is no guarantee
S-1/A
EX-10.12
zcqqfdxgmwhua
18 Apr 22
IPO registration (amended)
6:08am
S-1
eok5rd
6 Apr 22
IPO registration
4:21pm
S-1
EX-10.10
x24c75t db2x6l2d
6 Apr 22
IPO registration
4:21pm
DRS/A
qlxglfjtt3m8 y20
23 Nov 21
Draft registration statement (amended)
12:00am
DRS
skefis
19 Oct 21
Draft registration statement
12:00am
DRS
EX-10.12
6ro5i jp7
19 Oct 21
Draft registration statement
12:00am
- Prev
- 1
- Next